A research team led by Prof. Stephan Ludwig, a virologist at the Institute of Virology at the University of Münster, has found a new dual attack mode of action while working on the development of a drug candidate against SARS-CoV-2 infections. This could constitute the basis for a broadly effective drug to fight COVID-19. The data, which have now been published in the journal Cellular and Molecular Life Sciences, provided the basis for the approval issued by the German Institute of Drugs and Medicinal Products for a clinical study currently being worked on.
The need for mental health care in children and adolescents has been surging; rates of suicide and self-harm are increasing, and, like hospitals, primary care [...]
Even slight exposure to light can prompt the critical sleep-promoting hormone melatonin to plummet in preschoolers in the hour before bedtime, potentially disrupting slumber long [...]
CHAMPS (Communities and Hospitals Advancing Maternity Practices), a multi-year quality improvement (QI) initiative in the state of Mississippi led by Boston Medical Center (BMC) researchers, [...]